Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Ainsley Ross
ResearcherPublications, citations & collaboration network
Ainsley Ross is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 12 works, 365 citations, an h-index of 5 and an i10-index of 4.
12
Works
365
Citations
5
h-index
4
i10-index
IDs:OpenAlex
How has Ainsley Ross's publication output changed over time?
ScholarIQpublication output · 2008–2022
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2022.
1
1
4
1
1
1
1
2008201020122013201720182022
What are the most-cited papers on Ainsley Ross?
ScholarIQmost cited works
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
Andrew D. Norden, Jan Drappatz, Alona Muzikansky, Karly David, Mary Gerard, M. Brenna McNamara, Phuong Phan, Ainsley Ross, Santosh Kesari, Patrick Y. Wen
S175922936. 2008139 Citations
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson
Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan
Blood. 2013100 CitationsOPEN ACCESS
Comparative rates of adverse events with different formulations of intravenous iron
Maureen Okam, Elyse Mandell, Nathanael D. Hevelone, Wentz Rachel, Ainsley Ross, Gregory A. Abel
American Journal of Hematology. 201258 CitationsOPEN ACCESS
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study
Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Peter A. Riedell, Hemant S. Murthy, Phoebe Joy Ho, Joseph Maakaron, Edmund K. Waller, Farrukh T. Awan, Paul Shaughnessy, Armin Ghobadi, Michael Bishop, Ana Alfonso Piérola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William B. Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant-Cohen, Richard T. Maziarz, Carlos Bachier
Blood. 202257 Citations
Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.
David G. Nathan, Joshua J. Field, Gene Lin, Donna Neuberg, Elaine M. Majerus, Onyinye Onyekwere, Jeffrey R. Keefer, Maureen Okam, Ainsley Ross, Joel Linden
PubMed. 20128 CitationsOPEN ACCESS
Related on ScholarIQ
CRISPR Therapeutics (Switzerland)
Institution
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
Paper
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson
Paper
Comparative rates of adverse events with different formulations of intravenous iron
Paper
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study
Paper
Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.
Paper